Infection of Arabidopsis thaliana by the ascomycete fungus Colletotrichum higginsianum is 25 characterised by an early symptomless biotrophic phase followed by a destructive necrotrophic phase. 26 The fungal genome contains 77 secondary metabolism-related biosynthetic gene clusters (BGCs), and 27 their expression during the infection process is tightly regulated. Deleting CclA, a chromatin regulator 28 involved in repression of some BGCs through H3K4 trimethylation, allowed overproduction of 3 29 families of terpenoids and isolation of 12 different molecules. These natural products were tested in 30 combination with methyl jasmonate (MeJA), an elicitor of jasmonate responses, for their capacity to 31 alter defence gene induction in Arabidopsis. Higginsianin B inhibited MeJA-triggered expression of 32 the defence reporter VSP1p:GUS, suggesting it may block bioactive JA-Ile synthesis or signalling in 33 planta. Using the JA-Ile sensor Jas9-VENUS, we found that higginsianin B, but not three other 34 structurally-related molecules, suppressed JA-Ile signalling by preventing degradation of JAZ 35 proteins, the repressors of JA responses. Higginsianin B likely blocks the 26S proteasome-dependent 36 degradation of JAZ proteins because it inhibited chymotrypsin-and caspase-like protease activities. 37 The inhibition of target degradation by higginsianin B also extended to auxin signalling, as 38 higginsianin B treatment reduced IAA-dependent expression of DR5p:GUS. Overall, our data indicate 39 that specific fungal secondary metabolites can act similarly to protein effectors to subvert plant 40 immune and developmental responses.
MeJA treatment. In this way, expression of the reporter was evaluated in individual seedling roots (n 135 = 10 for each condition). To ensure that pre-treatments did not cause reporter degradation, a full sample 136 set was also pre-treated directly on microscope slides and imaged at 0 min and after 30 min. VENUS 137 fluorescence in living roots was imaged with a Zeiss LSM 700 confocal laser scanning microscope 138 with 488 nm excitation and 490-555 nm emission wavelength. All images shown within one 139 experiment were taken with identical settings. Image processing was done with FIJI (http://fiji.sc/Fiji). Monitoring Jas9-VENUS degradation by immunoblot 143 Five-day-old seedlings were grown horizontally in axenic conditions on a nylon mesh (200 µm pore 144 size) supported on MS solid medium. Growth conditions were 21°C with a photoperiod of 14h light 145 (100 µE•m -2 •s -1 ). Pre-treatment and treatment of seedlings was performed as described for microscopy, 146 except that treatments were performed in sterile dishes. E-64, a highly selective cysteine protease 147 inhibitor (E3132, Sigma-Aldrich) and epoxomicin, a specific proteasome inhibitor (E3652, Sigma-148 Aldrich) were used as controls. Seedlings were snap-frozen in liquid nitrogen and kept frozen for 149 disruption using 3 mm diameter tungsten beads in a Qiagen TissueLyser II operating at 30 Hz, 2 × 1 150 min. Total proteins from 120 seedlings were extracted with 150 µL of extraction buffer (50 mM Tris-151 HCl pH 7.4, 80 mM NaCl, 0.1 % Tween 20, 10 % glycerol, 10 mM dithiothreitol, 2× Protease inhibitor 152 cocktail [11873580001, Roche], 5 mM PMSF). Prior to protein quantification, debris were removed 153 by centrifugation at 14,000 rpm, 10 min. Total proteins (40 µg) were separated using SDS-PAGE (10 154 % acrylamide) and then blotted onto nitrocellulose membranes (1620112, Biorad). Jas9-VENUS and 155 ACTIN were detected using mouse monoclonal antibodies anti-GFP 1:1,000 (11814460001, Roche) 156 or anti-actin 1:2,000 (A0480, Sigma-Aldrich), respectively. The secondary antibody was an anti-157 mouse coupled to HRP 1:10,000 (W4021, Promega). Detection was performed with the Pico Plus 158 system (34580, Thermo Scientific) and X-ray films (47410 19284, Fujufilm). Cell-based proteasome activity assays 179 Measurement of proteasome peptidase activities following cell exposure to the compounds was 180 performed as described previously (Sklirou et al., 2015) . Briefly, cells were plated in 60 mm dishes, 181 left to adhere overnight and then treated with the test compounds for 24 or 48 h. The cells were then 182 lysed and proteasome activities were assayed as described above.
183
Auxin treatment 184 Five-day-old DR5p:GUS auxin reporter seedlings were grown vertically as described above. Pre- Conover-Iman test with Benjamini-Hochberg adjustment of P-values for false discovery rate (FDR).
194
All proteasome activity tests were performed at least in duplicate and data were statistically analysed 195 with an ANOVA single factor test. .
211
None of the tested compounds were able to inhibit or enhance the SA-mediated activation of Figure S1 ). Although seedlings pre-treated with fraction F4 and 213 higginsianin B showed a higher activation of PR1p:GUS compared to the DMSO control, these 214 differences were not significant (adjusted P-value = 0.25, Kruskal-Wallis with Conover-Iman test). In 215 contrast, fractions F3 and F4 both reduced the MeJA-dependent inducibility of VSP1p:GUS 216 expression, by 14 % and 66 %, respectively, compared to mock pre-treated controls ( Figure 1A ).
217
Purification of compounds from these two fractions identified higginsianin B as the only active 218 metabolite at a concentration of 30 µM. In agreement with this result, comparison of HPLC 219 chromatograms of fractions F1-F4 showed that higginsianin B was present only in fractions F3 and F4 220 (Supplementary Figure S2 ). Control seedlings that were not treated with MeJA (uninduced) displayed 221 only basal activation of VSP1p:GUS (8% of the level in induced seedlings, Figure 1A ). Using this 222 assay, we also found that higginsianin B reduced VSP1p:GUS activation in a dose-dependent manner 223 between 3 and 100 µM, with maximal inhibition of 56% at 100 µM ( Figure 1B) . Given the pronounced 224 inhibitory effect of higginsianin B on the JA pathway, we investigated this activity further. 226 To validate the primary screen result, we tested the effect of higginsianin B on a different marker of Figure 3C ). However, the three other members of this compound family were again 267 inactive at the same concentration (Supplementary Figure S3) . A dose-dependency test showed that 268 higginsianin B was active at a concentration of 10 µM ( Figure 3D ). As controls in this assay, E-64, a 269 highly selective cysteine protease inhibitor was used as an inhibitor of non-proteasomal proteases and 270 epoxomicin as a specific inhibitor of the proteasome. Similar to higginsianin B, epoxomicin inhibited 271 JAS9-VENUS degradation whereas E-64 was inactive (Supplementary Figure S3 ). pre-treatments ( Figure 4A ). Interestingly, mock pre-treated samples also showed increased JGP 282 expression in their roots, whereas higginsianin B pre-treatment reduced the wound-induced reporter 283 activation in this organ ( Figure 4A ). Quantification of JAZ10 transcripts further confirmed that 284 higginsianin B pre-treatment reduced wound-induced JAZ10 accumulation in both shoots and roots as 285 compared to mock treatments ( Figure 4B ). Furthermore, higginsianin B pre-treatment strongly reduced 286 MeJA-induced JGP activation in seedling roots (Supplementary Figure S4A) . Taken together, these 287 results indicate that higginsianin B can suppress endogenous JA-mediated responses. 289 The degradation of JAZ proteins is executed by the 26S proteasome upon poly-ubiquitination by Figure S4B ). This 300 finding supports the hypothesis that higginsianin B could affect other proteasome-dependent 301 processes, such as the activation of auxin signalling.
225

Higginsianin B inhibits JAZ1 degradation
288
Higginsianin B affects auxin-mediated signalling
302
The 26S proteasome is a target of higginsianin B 303 The impact of higginsianin B on JA-and auxin-mediated signalling pathways suggested the ubiquitin- Figure 5C ). Caspase-like activity was strongly 317 reduced to 35% of the control at 24 h, but only to 70% of the control at 48 h ( Figure 5D ). Overall, 318 these results suggest that higginsianin B is a potent inhibitor of proteasome proteolytic activities.
319
Discussion
320
To date, few chemical genetic screens have been used to systematically search for molecules 321 interfering with components of plant immunity (Dejonghe and Russinova 2017, Serrano et al., 2015) .
322
The first small molecule found to inhibit JA-mediated responses in a chemical screen was Jarin-1, a 323 plant-derived alkaloid that was subsequently shown to specifically inhibit the activity of JA-Ile 324 synthetase JAR1, thereby blocking the conversion of JA into bioactive JA-Ile (Meesters et al., 2014) . 325 Adopting a similar approach combined with bioassay-guided purification to screen secondary 326 metabolites produced by the C. higginsianum ΔcclA mutant, we here identified higginsianin B as a 327 novel inhibitor of jasmonate-induced plant defence gene expression. We showed that this diterpenoid 
338
To gain insight into the structural features of higginsianin B that are required for its activity, we tested 339 the three other known members of this compound family, namely higginsianin A, C and 13-epi-340 higginsianin C. Higginsianin B has a bicyclic core substituted by hydroxyl and 4-isoheptenyl groups.
341
In contrast, the three other molecules have a tricyclic core structure with the third ring being a 342 tetrahydrofuran substituted by either an isobutenyl group in the case of higginsianin A or an 343 isopropanol group in the case of higginsianin C and 13-epi-higginsianin C. Remarkably, higginsianin 344 B was the only molecule to show activity in JAZ degradation assays suggesting that either the hydroxyl 345 or the 4-isoheptenyl substituents of the bicyclic core (or both) contribute to the activity of higginsianin 346 B. On the other hand, a second hydroxyl group located on the pyrone ring in all higginsianins is 347 unlikely to contribute to this activity, and is therefore a good candidate for tagging higginsianin B with 348 a fluorescent probe for direct visualization of the active metabolite by live-cell imaging. This group 349 could also be exploited for the covalent immobilization of higginsianin B onto a solid support to search 350 for potential protein targets by affinity purification. 
388
Work is now ongoing to determine at what stage higginsianin B is produced during infection and to 389 genetically test its contribution to fungal virulence and plant defence suppression. 
